bradykinin, leu(8)-des-arg(9)- has been researched along with imidazolidines in 1 studies
| Studies (bradykinin, leu(8)-des-arg(9)-) | Trials (bradykinin, leu(8)-des-arg(9)-) | Recent Studies (post-2010) (bradykinin, leu(8)-des-arg(9)-) | Studies (imidazolidines) | Trials (imidazolidines) | Recent Studies (post-2010) (imidazolidines) |
|---|---|---|---|---|---|
| 102 | 0 | 7 | 1,666 | 186 | 358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Inoue, N; Kobayashi, K; Kondo, T; Li, P; Murohara, T; Numaguchi, Y; Okumura, K | 1 |
1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and imidazolidines
| Article | Year |
|---|---|
Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Capillaries; Enzyme Inhibitors; Hindlimb; Imidazoles; Imidazolidines; Ischemia; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2008 |